Literature DB >> 7200841

Chronic inflammatory bowel disease--increased plasminogen activator secretion by mononuclear phagocytes.

W F Doe, B Dorsman.   

Abstract

The secretion of the neutral protease plasminogen activator (PA) by cultured macrophages (M phi) was studied in hospitalized patients suffering from chronic inflammatory bowel disease (IBD). There was markedly enhanced secretion of PA by M phi derived from circulating monocytes of the IBD population (18) compared to an age-matched population (16) which was not afflicted by intestinal disease (P less than 0 . 001). Mean M phi PA activity was greater in the population of 11 Crohn's disease patients (P less than 0 . 01) than in a group of seven ulcerative colitis sufferers (P less than 0 . 05) when compared to the control population. While both the treated and untreated hospitalized IBD populations showed increased M phi PA specific activity, results for the nine untreated patients (5 . 56 +/- 1.14 units/micrograms M phi DNA) were substantially higher than those found in the treated IBD population (2 . 91 +/- 0 . 62 units/micrograms M phi DNA) (P less than 0 . 01). These findings reflect the activity of M phi in IBD and suggest a means by which tissue injury is mediated in these conditions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7200841      PMCID: PMC1536565     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Simple and rapid fluorimetric method for DNA microassay.

Authors:  J Kapuściński; B Skoczylas
Journal:  Anal Biochem       Date:  1977-11       Impact factor: 3.365

2.  Ability of activated complement components to induce lysosomal enzyme release from macrophages.

Authors:  H U Schorlemmer; P Davies; A C Allison
Journal:  Nature       Date:  1976-05-06       Impact factor: 49.962

3.  Macrophage tumor killing: influence of the local environment.

Authors:  J B Hibbs; R R Taintor; H A Chapman; J B Weinberg
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

4.  The macrophage as an effector cell.

Authors:  C F Nathan; H W Murray; Z A Cohn
Journal:  N Engl J Med       Date:  1980-09-11       Impact factor: 91.245

5.  Transcobalamin II level in peripheral blood monocytes--a biochemical marker in inflammatory diseases of the bowel.

Authors:  D Rachmilewitz; M Ligumsky; B Rachmilewitz; M Rachmilewitz; N Tarcic; M Schlesinger
Journal:  Gastroenterology       Date:  1980-01       Impact factor: 22.682

6.  Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein.

Authors:  C G Cochrane; S D Revak; K D Wuepper
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

7.  Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis: evidence for a two-stage process.

Authors:  S Gordon; J C Unkeless; Z A Cohn
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

8.  Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells.

Authors:  W F Doe; P M Henson
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

9.  The conversion of C'IS to C'1 esterase by plasmin and trypsin.

Authors:  O D Ratnoff; G B Naff
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

10.  A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.

Authors:  A P Kaplan; K F Austen
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

View more
  12 in total

1.  Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.

Authors:  Y R Mahida; K Wu; D P Jewell
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

2.  Disordered regulation of the in vitro immunoglobulin synthesis by intestinal mononuclear cells in Crohn's disease.

Authors:  H W Verspaget; A S Peña; I T Weterman; C B Lamers
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

3.  Characterization of antigen-presenting activity of intestinal mononuclear cells isolated from normal and inflammatory bowel disease colon and ileum.

Authors:  Y R Mahida; K C Wu; D P Jewell
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

Review 4.  Macrophage activation, chronic inflammation and gastrointestinal disease.

Authors:  A R Tanner; M J Arthur; R Wright
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

5.  Role of alveolar macrophage plasminogen activator in the acute pulmonary responses to endotoxin.

Authors:  T Etoh; E Kakishita; K Nagai
Journal:  Lung       Date:  1984       Impact factor: 2.584

6.  Interleukin 2 receptor expression by macrophages in inflammatory bowel disease.

Authors:  Y R Mahida; S Patel; K Wu; D P Jewell
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

7.  Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease.

Authors:  Y R Mahida; K C Wu; D P Jewell
Journal:  Gut       Date:  1989-10       Impact factor: 23.059

8.  High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.

Authors:  Y R Mahida; L Kurlac; A Gallagher; C J Hawkey
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

9.  Production of plasminogen activator by alveolar macrophages in normal subjects and patients with interstitial lung disease.

Authors:  B W Robinson
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

10.  Effect of human intestinal macrophages on immunoglobulin production by human intestinal mononuclear cells isolated from patients with inflammatory bowel disease.

Authors:  K C Wu; Y R Mahida; J D Priddle; D P Jewell
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.